COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,223 Articles (22,733 medRxiv, 8,490 bioRxiv)

Most recent first Previous |  Page 1564: Articles 15631-15640  | Next

Quantifying COVID-19 vaccination hesitancy during early vaccination rollout in Canada
Tang, X., Gelband, H., Nagelkerke, N., Bogoch, I., Brown, P. E., Morawski, E., Lam, T., Reid, A., Jha, P., Action to beat coronavirus/Action pour battre le coronavirus (Ab-C) Study Investigators
10.1101/2021.04.29.21256333 — Posted: 2021-05-02
Seroprevalence of SARS-CoV-2 antibodies in broadcast media workers
Martins-Filho, P. R., da Silva, D. N., dos Santos, D. M., Rezende, M. S., Silva, J. P. R., da Silva Neto, J. B., Schimieguel, D. M., Quintans-Junior, L. J., Quintans, J. d. S. S., Nunes, P. S., de Sousa Araujo, A. A.
10.1101/2021.04.29.21256360 — Posted: 2021-05-02
Aspirin and NSAID use and the risk of COVID-19
Drew, D. A., Guo, C.-G., Lee, K., Nguyen, L., Joshi, A. D., Lo, C.-H., Ma, W., Mehta, R. S., Kwon, S., Astley, C. M., Song, M., Davies, R., Capdevila, J., Ni Lochlainn, M. M., Sudre, C., Graham, M. S., Varsavsky, T., Gomez, M. F., Kennedy, B., Fitipaldi, H., Wolf, J., Spector, T., Ourselin, S., Steves, C., Chan, A. T.
10.1101/2021.04.28.21256261 — Posted: 2021-05-02
SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity
Laing, E., Epsi, N. J., Richard, S. A., Samuels, E. C., Wang, W., Vassell, R., Ewing, D. F., Herrup, R., Sterling, S. L., Lindholm, D. A., Millar, E. V., Maves, R. C., Larson, D. T., Colombo, R. E., Chi, S., Madar, C. S., Lalani, T., Ganesan, A., Fries, A., Colombo, C. J., Mende, K., Simons, M. P., Schully, K. L., Weiss, C. D., Tribble, D. R., Agan, B. K., Pollett, S. D., Broder, C. C., Burgess, T. H.
10.1101/2021.04.27.21256207 — Posted: 2021-05-02
Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19
Hoeter, K., Neuberger, E., Fischer, S., Herbst, M., Juskeviciute, E., Rossmann, H., Sprinzl, M. F., Simon, P., Bodenstein, M., Schäfer, M. K. E.
10.1101/2021.04.29.21256291 — Posted: 2021-05-02
Cost-effectiveness of COVID-19 vaccination in low- and middle-income countries
Siedner, M. J., Alba, C., Fitzmaurice, K. P., Gilbert, R. F., Scott, J. A., Shebl, F. M., Ciaranello, A., Reddy, K. P., Freedberg, K. A.
10.1101/2021.04.28.21256237 — Posted: 2021-05-02
Serum Neurofilament Light is Elevated in COVID-19 Positive Adults in the ICU and is Associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness
Hay, M., Ryan, L., Huentelman, M., Konhilas, J., Hoyer-Kimura, C., Beach, T. G., Serrano, G. G., Reiman, E. M., Blennow, K., Zetterberg, H. M., Parthasarathy, S.
10.1101/2021.04.28.21256277 — Posted: 2021-05-02
Reduced Pediatric Urgent Asthma Utilization and Exacerbations During the COVID-19 Pandemic
Hurst, J. H., Zhao, C., Fitzpatrick, N. S., Goldstein, B. A., Lang, J. E.
10.1101/2021.04.28.21256263 — Posted: 2021-05-01
Changes in English NHS outpatient activity during the early Covid-19 period
Morris, J. S., Georghiou, T., Appleby, J.
10.1101/2021.04.28.21256176 — Posted: 2021-05-01
Sustained seroprevalence of anti SARS-CoV-2 total immunoglobulins in asymptomatic blood donors
Martin, M. C., Gonzalez, M. I., Holgado, N., Jimenez, A., Ortega, N., Page, I., Parrado, A., Perez, M., Blanco-Peris, L.
10.1101/2021.04.28.21256242 — Posted: 2021-05-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).